CNS Response Inc. (NASDAQ:MYND) Director John Pappajohn purchased 5,000 shares of the stock in a transaction dated Wednesday, August 9th. The shares were purchased at an average price of $3.34 per share, with a total value of $16,700.00. Following the completion of the acquisition, the director now owns 541,290 shares of the company’s stock, valued at $1,807,908.60. The purchase was disclosed in a filing with the SEC, which is available through the SEC website.

John Pappajohn also recently made the following trade(s):

  • On Wednesday, August 2nd, John Pappajohn bought 5,000 shares of CNS Response stock. The stock was bought at an average price of $3.65 per share, with a total value of $18,250.00.
  • On Tuesday, July 25th, John Pappajohn bought 5,000 shares of CNS Response stock. The stock was bought at an average price of $4.00 per share, with a total value of $20,000.00.
  • On Friday, July 21st, John Pappajohn purchased 10,000 shares of CNS Response stock. The shares were acquired at an average cost of $4.25 per share, for a total transaction of $42,500.00.
  • On Tuesday, July 18th, John Pappajohn purchased 10,000 shares of CNS Response stock. The shares were acquired at an average cost of $4.47 per share, for a total transaction of $44,700.00.

Shares of CNS Response Inc. (MYND) traded up 21.43% on Thursday, reaching $4.25. 90,837 shares of the company’s stock were exchanged. The firm’s 50 day moving average price is $5.12 and its 200-day moving average price is $6.48. The company’s market capitalization is $17.91 million. CNS Response Inc. has a 12 month low of $3.10 and a 12 month high of $10.00.

TRADEMARK VIOLATION WARNING: “Insider Buying: CNS Response Inc. (NASDAQ:MYND) Director Purchases 5,000 Shares of Stock” was published by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://www.watchlistnews.com/insider-buying-cns-response-inc-nasdaqmynd-director-purchases-5000-shares-of-stock/1469147.html.

CNS Response Company Profile

MYnd Analytics, Inc, formerly CNS Response, Inc, is a predictive analytics company. The Company has developed a decision support tool to help physicians reduce trial and error treatment in mental health, and provide personalized care to patients. The Company provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioral disorders, including depression, anxiety, bipolar disorder, post-traumatic stress disorder (PTSD) and other non-psychotic disorders.

Receive News & Ratings for CNS Response Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CNS Response Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.